ReviewDrug, healthcare and patient safety2023

Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy.

Catarina Falcão de Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.